Clinical interventions on the major vascular risk factors. (RIVANA study)

Authors

  • C. Amezqueta Goñi
  • B. Bermejo
  • M.J. Guembe
  • M.T. Artázcoz
  • J.J. Viñes

DOI:

https://doi.org/10.23938/ASSN.0131

Keywords:

Factores de riesgo vascular. Prevalencia. Consejo dietético. Tratamiento farmacológico.

Abstract

Background. To describe the diagnostic frequency of classical vascular risk factors, dietary and therapeutic interventions and their control. Methods. Within the project Vascular Risk in Navarre (RIVANA), a transversal study was made of a random sample of 4,354 people between the ages of 35 and 84; antecedents were gathered by interview and clinical and analytical exploration was carried out. The subjects were classified for each risk factor into: diagnosed by information –when health personnel had informed them that they presented a risk factor–; by intervention –when they take medication for it–; and by detection in asymptomatic people. The variables of intervention were identified by dichotomic trees expressed by relative frequencies. Results. Forty-five point three percent of the subjects are hypertense: 27% previously diagnosed and 18.3% at the time of the exploration. Thirty-nine percent are hypercholesterolemic: 33.4% previously diagnosed and 5.6% at the time of the exploration. Twenty-one point two percent presented hyperglycemia: 9.7% previously diagnosed and 11.6% at the time of the exploration. Sixty-five point six percent were diagnosed as overweight or obese: 25.9% previously and 39.6% at the time of the exploration. They received dietary counselling and pharmacological treatment respectively: 79.8% and 70.3% of the hypertense; 75.4% and 35% of the hypercholesterolemic; 83.1% and 47.4% of those who presented hyperglycemia and 68.5% and 4% of those who showed overweight or obesity. Conclusions. The frequency of cardiovascular risk factors is high. There is a margin for significant improvement in the detection, intervention and control of the risk factors.

Downloads

Download data is not yet available.

Author Biography

B. Bermejo

 

 

References

1. Mortalidad en Navarra 1996-2005. Boletín informativo Instituto de Salud Pública de Navarra. Mayo 2007; 44: 1-5.

2. UNAL B, CRITCHLEY JA, CAPEWELL S. Explaining the decline in coronary heart disease mortality in England and Wales, 1981-2000. Circulation 2004; 109: 1101-1107.

https://doi.org/10.1161/01.CIR.0000118498.35499.B2

3. FORD ES, AJANI UA, CROFT JB, CRITCHLEY JA, LABARTHE DR, KOTTKE TE et al. Explaining the decrease in U.S. Deaths from coronary disease, 1980-2000. N Engl J Med 2007; 356: 2388-2398.

https://doi.org/10.1056/NEJMsa053935

4. SERRANO M, BERJÓN J, SALABERRI A, AMÉZQUETA C. Riesgo Cardiovascular. Evidencias que orientan la actuación clínica. Gobierno de Navarra. An Sist Sanit Navar 2003: Monografía nº 2: 1-117.

5. VIÑES JJ, DÍEZ J, GUEMBE MJ, GONZÁLEZ P, AMÉZQUETA C, BARBA J et al. Estudio de riesgo vascular en Navarra: objetivos y diseño. Prevalencia del síndrome metabólico y de los factores mayores de riesgo vascular. An Sist Sanit Navar 2007; 30: 113-124.

https://doi.org/10.4321/S1137-66272007000100011

6. GUEMBE MJ. Prevalencia por 100 de factores de riesgo en Navarra 1993: Bol Salud Pub Nav 1994; 7: 2-8.

7. VIÑES JJ, DÍEZ J, GUEMBE MJ, GONZÁLEZ D, AMÉZQUETA C, BARBA J et al. Estudio de riesgo vascular en Navarra: objetivo y diseño. Prevalencia del síndrome metabólico y de los factores mayores de riesgo vascular. An Sist Sanit Navar 2007; 30: 113-124.

https://doi.org/10.4321/S1137-66272007000100011

8. Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-1187.

https://doi.org/10.1097/HJH.0b013e3281fc975a

9. RIGO CORRATALÁ F, GUILLÉN FRONTERA J, LLOBERA CÁNAVES J, RODRÍGUEZ RUIZ T, BORRÁS BOSCH I, FUENTESPINA VIDAL E. Prevalencia de factores de riesgo cardiovascular en las Islas Baleares (estudio CORSAIB). Rev Esp Cardiol 2005; 58: 1411-1419.

https://doi.org/10.1016/S0300-8932(05)74071-9

10. Riesgo de Enfermedad Cardiovascular en Castilla y León. 2005. Consejería de Sanidad. Junta de Castilla y León.

11. Ministerio de Sanidad y Consumo. Sociedad Española de Cardiología. Consenso para el Control de la Colesterolemia en España. Madrid: MSC; 1990.

12. GONZÁLEZ P, MORENO C, GUEMBE MJ, VILA J, ELOSÚA R, VIÑES JJ et al. Estimación del riesgo de enfermedad coronaria en la población Navarra (RICORNA). Pamplona: Gobierno de Navarra An Sist Sanit Navar 2008; En: Monografía nº 4: Riesgo Vascular en Navarra: 61-68.

13. Guía europea de prevención cardiovascular en la práctica clínica. Tercer grupo de trabajo de las sociedades europeas y otras sociedades sobre la prevención cardiovascular en la práctica clínica. Eur Heart J 2003; 24: 1601-1610.

14. Expert committee on the diagnosis and classification of diabetes mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-1197.

https://doi.org/10.2337/diacare.20.7.1183

15. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO Consultation. Part 1. Diagnosis and classification of diabetes mellitus. Geneva: World Health Organization, 1999.

Published

2010-01-13

How to Cite

1.
Amezqueta Goñi C, Bermejo B, Guembe M, Artázcoz M, Viñes J. Clinical interventions on the major vascular risk factors. (RIVANA study). An Sist Sanit Navar [Internet]. 2010 Jan. 13 [cited 2025 Dec. 17];32(3):351-62. Available from: https://recyt.fecyt.es/index.php/ASSN/article/view/5779

Issue

Section

Research articles

Most read articles by the same author(s)

1 2 3 4 > >> 

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.